Global percutaneous transluminal angioplasty balloons catheters market is estimated to be valued at USD 1.99 Bn in 2025, and is expected to exhibit a CAGR of 9.3% during the forecast period (2025-2032). Percutaneous transluminal angioplasty (PTA) balloons catheters are used to widen arteries or veins that have been narrowed due to atherosclerosis or other conditions. PTA is a minimally invasive procedure that uses a balloon catheter to dilate stenosed or blocked blood vessels. The catheter is inserted into the femoral or brachial artery and threaded through to the site of narrowing under x-ray guidance. The balloon is then inflated, compressing plaque against the vessel walls to expand the artery. With repeated inflation-deflation cycles, the artery or vein is widened, improving blood flow. PTA balloons catheters have revolutionized the treatment of peripheral artery disease and coronary artery disease.
Market Dynamics
Global percutaneous transluminal angioplasty balloons catheters market growth is driven by rising geriatric population, increasing prevalence of cardiovascular diseases, and growing preference for minimally invasive procedures. Technological advancements in catheter design along with development of drug-coated balloons and bioabsorbable stents can drive the market growth. However, product recalls and failures can hamper the market growth. High cost of newer balloon catheter technologies can also hamper the market growth. The market witness opportunities in emerging markets due to improving access to healthcare. Key players are focusing on new product launches, collaborations and acquisitions to strengthen their product portfolios and geographic presence.
Key features of the study
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook